AJR Get Involved! Join ARRS Today
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Venturini, M.
Right arrow Articles by Del Maschio, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Venturini, M.
Right arrow Articles by Del Maschio, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2004; 182:1417-1426
© American Roentgen Ray Society


Complications After Percutaneous Transaxillary Implantation of a Catheter for Intraarterial Chemotherapy of Liver Tumors: Clinical Relevance and Management in 204 Patients

Massimo Venturini1, Enzo Angeli1, Marco Salvioni1, Francesco De Cobelli1, Monica Ronzoni2, Luca Aldrighetti3, Marco Stella4, Michele Carlucci5, Carlo Staudacher5, Valerio Di Carlo4, Gianfranco Ferla3, Eugenio Villa2 and Alessandro Del Maschio1

1 Department of Radiology, Scientific Institute S. Raffaele, Vita-Salute University, Olgettina 60, Milan 20132, Italy.
2 Department of Oncology, Scientific Institute S. Raffaele, Vita-Salute University, Milan 20132, Italy.
3 Department of General Surgery, First Division, Scientific Institute S. Raffaele, Vita-Salute University, Olgettina 60, Milan 20132, Italy.
4 Department of General Surgery, Second Division, Scientific Institute S. Raffaele, Vita-Salute University, Milan 20132, Italy.
5 Department of Emergency Surgery, Scientific Institute S. Raffaele, Vita-Salute University, Milan 20132, Italy.

OBJECTIVE. The purposes of the study were to evaluate the complications of patients who underwent percutaneous transaxillary implantation of a permanent catheter-port system for intraarterial hepatic chemotherapy and determine their clinical relevance and specific management.

SUBJECTS AND METHODS. Catheter-port systems were placed in 204 patients with liver tumors (86.7% from colorectal metastases). Under sonographic and fluoroscopic guidance, a 5.8-French catheter was placed in the hepatic artery and connected to a subcutaneous reservoir after embolization of the gastroduodenal and right gastric arteries. Floxuridine plus dexamethasone and systemic low-dose heparin were administered. During the follow-up period, complications were classified as clinically not significant (type 1), clinically significant not requiring interruption of intrahepatic chemotherapy (type 2), clinically significant needing temporary suppression of intrahepatic chemotherapy (type 3), and clinically significant causing permanent suppression of intrahepatic chemotherapy (type 4).

RESULTS. No complications occurred during the implantation procedures. The mean number of intrahepatic chemotherapy cycles was 8.1. The mean follow-up period was 270 days. Primary and secondary patency rates of the system were 71.6% and 91.2%, respectively. Temporary suppression of intrahepatic chemotherapy was necessary in 19.6% of the patients and definitive suppression, in 8.8%. Hepatic artery thrombosis, not recanalized by local thrombolysis, was the main cause of permanent intrahepatic chemotherapy interruption (4.4%). Catheter occlusions and cerebral complications were not observed. In 91.2% of the patients, intrahepatic chemotherapy could be completed.

CONCLUSION. Percutaneous implantation of a removable and reimplantable catheter-port system for intrahepatic chemotherapy can be a safe procedure to treat unresectable liver metastases from colorectal cancer. Technical and pharmacologic complications with variable clinical relevance occurred, and various specific management strategies were necessary to reduce their incidence.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
C. Pulitano, M. Arru, M. Catena, E. Guzzetti, G. Vitali, M. Ronzoni, M. Venturini, E. Villa, G. Ferla, and L. Aldrighetti
Results of Preoperative Hepatic Arterial Infusion Chemotherapy in Patients Undergoing Liver Resection for Colorectal Liver Metastases
Ann. Surg. Oncol., June 1, 2008; 15(6): 1661 - 1669.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
H. Seki, T. Ozaki, and M. Shiina
Side-Hole Catheter Placement for Hepatic Arterial Infusion Chemotherapy in Patients with Liver Metastases from Colorectal Cancer: Long-Term Treatment and Survival Benefit
Am. J. Roentgenol., January 1, 2008; 190(1): 111 - 120.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. Nagaoka, S. Itano, H. Nagamatsu, J. Akiyoshi, J. Kurogi, N. Tajiri, M. Kajiwara, and M. Sata
Temporary Indwelling Catheter System via the Left Brachial Artery: Evaluation in 83 Patients with Hepatic Tumors
Am. J. Roentgenol., March 1, 2007; 188(3): 652 - 658.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
H. Seki and M. Shiina
Placement of a long tapered side-hole catheter in the hepatic artery: technical advantages, catheter stability, and arterial patency.
Am. J. Roentgenol., November 1, 2006; 187(5): 1312 - 1320.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Roentgen Ray Society.